PHA-848125 structure, CAS 802539-81-7

PHA-848125

CAS Number802539-81-7

SynonymsMilciclib [INN]; Milciclibum; cc-78; Milciclib; PHA-848125

Molecular FormulaC25H32N8O

Molecular Weight460.58

Purity

Density1.3±0.1 g/cm3

Boiling Point

Melting Point

Flash Point

Appearancepowder

EINECS

MSDSChineseEnglish

Symbol

Signal Word

Cat. No.: 2A-2195390 Purity:
Change View

Please Login or Create an Account to: See VlP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

Quality Control of [ 802539-81-7 ] SDS Specification MoL

Chemical & Physical Properties
CAS Number802539-81-7
Catalog No.2A-2195390
Chinese Name4,5-二氢-n,1,4,4-四甲基-8-[[4-(4-甲基-1-哌嗪)苯基]氨基]-1H-吡唑并[4,3-h]喹唑啉-3-羧酰胺
SynonymsMilciclib [INN]; Milciclibum; cc-78; Milciclib; PHA-848125
Molecular FormulaC25H32N8O
Molecular Weight460.58
Density1.3±0.1 g/cm3
Appearancepowder
Storage Condition-20℃
ApplicationMilciclib (PHA-848125) is a potent dual CDK and Tropomyosin receptor kinase (TRK) inhibitor with IC50 values of 45, 150, 160, 363, 398 and 53 for cyclin A/CDK2, cyclin H/CDK7, cyclin D1/CDK4, cyclin E
PubChem ID33089364
MDL NumberC25H32N8O
SMILESCNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2
InChIInChI=1S/C25H32N8O/c1-25(2)14-16-15-27-24(29-20(16)22-19(25)21(23(34)26-3)30-32(22)5)28-17-6-8-18(9-7-17)33-12-10-31(4)11-13-33/h6-9,15H,10-14H2,1-5H3,(H,26,34)(H,27,28,29)
InChI KeyRXZMYLDMFYNEIM-UHFFFAOYSA-N
MSDSmsds/197087_1_802539_81_7.pdf
Transport InfoProduct name: PHA-848125
Related Products in Specialty Chemicals
FEXUPRAZAN / ABEPRAZAN1902954-60-22A-2195384
GF109203X133052-90-12A-2195386
LY-30091201454682-72-42A-2195387
IWP L61427782-89-52A-2195388
GZD8241421783-64-32A-2195389
SR25161061353-68-12A-2195392
AZD24611174043-16-32A-2195393
Mk-2461 917879-39-12A-2195394
4-((Dimethylamino)methyl)-2-methyl-1H-benzo[d]imidazol-5-ol101018-70-62A-2195395
2-Amino-5-bromo-4-fluorobenzoicacid143945-65-72A-2195399
Browse all Specialty Chemicals products »
Contact Us

Phone:

630-322-8886

630-322-8887

Email:

[email protected]

Office Locations:

Chicago, IL, USA

San Francisco, CA, USA